Terry Pearson

Director Técnico/Científico/I+D en Siscapa Assay Technologies, Inc. .

78 años

Health Technology

Consumer Services

Consumer Non-Durables

Cargos activos de Terry Pearson

Empresas	Cargo	Inicio	Fin
Science Council of British Columbia	Director/Miembro de la Junta	01/09/2010	-
CAVA Healthcare, Inc. CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada.	Director/Miembro de la Junta	-	-
Siscapa Assay Technologies, Inc. Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Siscapa Assay Technologies, Inc. provides products and services for precise quantitation of protein biomarkers, drugs, and drug targets using immuno-affinity mass spectrometry. Siscapa assays are used in clinical diagnostics and pharma R&D for particularly demanding applications, and in biomarker panels to characterize changes in health, disease, and treatment in longitudinal user-collected dried blood microsamples. Siscapa immuno-affinity mass spectrometry assays for targeted protein quantitation can be developed more quickly than typical ELISA immunoassays since they require only a single specific antibody and provide absolute target specificity because of the MS detection. Because Siscapa assays do not interact with one another, these assays can be freely assembled in panels for various applications. The American company was founded by N. Leigh Anderson, who has been the CEO since incorporation.	Director Técnico/Científico/I+D	-	-
Eyam Vaccines & Immunotherapeutics Ltd.	Director/Miembro de la Junta	10/01/2022	-

Empresas	Cargo	Inicio	Fin
BIOASIS TECHNOLOGIES INC.	Director/Miembro de la Junta	27/03/2008	21/09/2017
BIOASIS TECHNOLOGIES INC.	Independent Dir/Board Member	27/03/2008	21/09/2017
MARKER THERAPEUTICS, INC.	Director/Miembro de la Junta	-	05/12/2005
University of British Columbia	Corporate Officer/Principal	-	-
NEVIS BRANDS INC.	Director/Miembro de la Junta	16/12/2014	-
NEVIS BRANDS INC.	Independent Dir/Board Member	16/12/2014	-
University of Victoria	Corporate Officer/Principal	01/01/1979	-
░░░ ░░░░░ ░░░ ░░░░░░░░░░	░░░░░░░░░░░░░░ ░░░░░░	-	-

University of British Columbia

Doctorate Degree

Internacional

Canadá	7
Estados Unidos	5

Operativa

Director/Board Member	7
Independent Dir/Board Member	2
Corporate Officer/Principal	2

Sectorial

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	5
Siscapa Assay Technologies, Inc. Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Siscapa Assay Technologies, Inc. provides products and services for precise quantitation of protein biomarkers, drugs, and drug targets using immuno-affinity mass spectrometry. Siscapa assays are used in clinical diagnostics and pharma R&D for particularly demanding applications, and in biomarker panels to characterize changes in health, disease, and treatment in longitudinal user-collected dried blood microsamples. Siscapa immuno-affinity mass spectrometry assays for targeted protein quantitation can be developed more quickly than typical ELISA immunoassays since they require only a single specific antibody and provide absolute target specificity because of the MS detection. Because Siscapa assays do not interact with one another, these assays can be freely assembled in panels for various applications. The American company was founded by N. Leigh Anderson, who has been the CEO since incorporation.	Health Technology
CAVA Healthcare, Inc. CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada.	Consumer Non-Durables
The Terry Fox Foundation
Science Council of British Columbia
Eyam Vaccines & Immunotherapeutics Ltd.